INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")
Latest Factsheet and Blog
IBT's factsheet for the month ended 30 June 2025 is now available directly via its web page. Please click here , then 'latest factsheet'.
Following up on our recent article, Things are grim, but science will prevail , we wanted to provide a further update on what recent political developments in the US might mean for biotech investors. While many of the details are still being worked through, two issues - drug pricing reform and potential tariffs - continue to result in an unusual degree of uncertainty for the sector. In this note, we explore those concerns in more detail, explain how they're affecting sentiment, and set out why we believe the long-term investment case for biotech remains intact.
The blog can be read here:
https://www.schroders.com/en-gb/uk/individual/content/making-sense-of-a-shifting-policy-landscape/
To sign up for IBT updates by email, please click here .
ENDS
Enquiries:
| Schroder Investment Management Limited
Kirsty Preston (PR)
Natalia de Sousa |
020 7658 6000
020 7658 6000
|
|
|
|
Kaso Legg Communications (Financial PR)
Charles Gorman Henry Taylor Effie Aye Maung Hider |
|
|
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.